CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- 4 Shares withheld for taxes VP Peripheral Nerve Science gave up 4,171 shares (to pay taxes)
- 4 Option exercise CEO acquired 52,375 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Option exercise CEO acquired 54,754 shares (option exercise)
- 4 Open-market sale CEO sold 41,000 shares at an average $18.47 ($757,194)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market sale VP Operations sold 1,935 shares at $20.04 ($38,777)
- 4 Shares withheld for taxes VP Peripheral Nerve Science gave up 392 shares (to pay taxes)
- 4 Shares withheld for taxes VP Operations gave up 637 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 8,812 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,090 shares (to pay taxes)
- 4 Shares withheld for taxes Chief R&D Officer gave up 637 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 918 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Strategy and BD Officer gave up 728 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Human Resources Officer gave up 637 shares (to pay taxes)
- 4 Shares withheld for taxes VP Regulatory Affairs & Policy gave up 637 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
Page 22 of 69 · 1,369 filings